280 related articles for article (PubMed ID: 19183778)
1. Brain ischemia and ischemic blood-brain barrier as etiological factors in sporadic Alzheimer's disease.
Pluta R; Amek MU
Neuropsychiatr Dis Treat; 2008 Oct; 4(5):855-64. PubMed ID: 19183778
[TBL] [Abstract][Full Text] [Related]
2. Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain.
Pluta R
Curr Neurovasc Res; 2007 May; 4(2):121-9. PubMed ID: 17504210
[TBL] [Abstract][Full Text] [Related]
3. Post-Ischemic Permeability of the Blood-Brain Barrier to Amyloid and Platelets as a Factor in the Maturation of Alzheimer's Disease-Type Brain Neurodegeneration.
Pluta R; Miziak B; Czuczwar SJ
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445917
[TBL] [Abstract][Full Text] [Related]
4. Pathological opening of the blood-brain barrier to horseradish peroxidase and amyloid precursor protein following ischemia-reperfusion brain injury.
Pluta R
Chemotherapy; 2005 Jul; 51(4):223-6. PubMed ID: 16006769
[TBL] [Abstract][Full Text] [Related]
5. Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes.
Pluta R; Jabłoński M; Ułamek-Kozioł M; Kocki J; Brzozowska J; Januszewski S; Furmaga-Jabłońska W; Bogucka-Kocka A; Maciejewski R; Czuczwar SJ
Mol Neurobiol; 2013 Dec; 48(3):500-15. PubMed ID: 23519520
[TBL] [Abstract][Full Text] [Related]
6. Is the ischemic blood-brain barrier insufficiency responsible for full-blown Alzheimer's disease?
Pluta R
Neurol Res; 2006 Sep; 28(6):665-71. PubMed ID: 16945220
[TBL] [Abstract][Full Text] [Related]
7. Ischemic blood-brain barrier and amyloid in white matter as etiological factors in leukoaraiosis.
Pluta R; Januszewski S; Ułamek M
Acta Neurochir Suppl; 2008; 102():353-6. PubMed ID: 19388344
[TBL] [Abstract][Full Text] [Related]
8. Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.
Ułamek-Kozioł M; Czuczwar SJ; Januszewski S; Pluta R
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019137
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's factors in postischemic dementia.
Pluta R; Ułamek-Kozioł M; Januszewski S; Sciślewska M; Bogucka-Kocka A; Kocki J
Rom J Morphol Embryol; 2012; 53(3):461-6. PubMed ID: 22990533
[TBL] [Abstract][Full Text] [Related]
10. Expression of Alzheimer's disease risk genes in ischemic brain degeneration.
Ułamek-Kozioł M; Pluta R; Januszewski S; Kocki J; Bogucka-Kocka A; Czuczwar SJ
Pharmacol Rep; 2016 Dec; 68(6):1345-1349. PubMed ID: 27710863
[TBL] [Abstract][Full Text] [Related]
11. [Cholesterol and Alzheimer's disease].
Kálmán J; Janka Z
Orv Hetil; 2005 Sep; 146(37):1903-11. PubMed ID: 16255374
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's mechanisms in ischemic brain degeneration.
Pluta R; Ułamek M; Jabłoński M
Anat Rec (Hoboken); 2009 Dec; 292(12):1863-81. PubMed ID: 19943340
[TBL] [Abstract][Full Text] [Related]
13. Micro-blood-brain barrier openings and cytotoxic fragments of amyloid precursor protein accumulation in white matter after ischemic brain injury in long-lived rats.
Pluta R; Ułamek M; Januszewski S
Acta Neurochir Suppl; 2006; 96():267-71. PubMed ID: 16671468
[TBL] [Abstract][Full Text] [Related]
14. Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer's Disease.
Pluta R; Ouyang L; Januszewski S; Li Y; Czuczwar SJ
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671097
[TBL] [Abstract][Full Text] [Related]
15. Brain ischemia with Alzheimer phenotype dysregulates Alzheimer's disease-related proteins.
Ułamek-Kozioł M; Pluta R; Bogucka-Kocka A; Januszewski S; Kocki J; Czuczwar SJ
Pharmacol Rep; 2016 Jun; 68(3):582-91. PubMed ID: 26940197
[TBL] [Abstract][Full Text] [Related]
16. Postischemic dementia with Alzheimer phenotype: selectively vulnerable versus resistant areas of the brain and neurodegeneration versus β-amyloid peptide.
Pluta R; Jabłoński M; Czuczwar SJ
Folia Neuropathol; 2012; 50(2):101-9. PubMed ID: 22773455
[TBL] [Abstract][Full Text] [Related]
17. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
Elife; 2020 Jun; 9():. PubMed ID: 32510331
[TBL] [Abstract][Full Text] [Related]
18. Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation.
Koistinaho M; Koistinaho J
Brain Res Brain Res Rev; 2005 Apr; 48(2):240-50. PubMed ID: 15850663
[TBL] [Abstract][Full Text] [Related]
19. Application of optogenetic Amyloid-β distinguishes between metabolic and physical damages in neurodegeneration.
Lim CH; Kaur P; Teo E; Lam VYM; Zhu F; Kibat C; Gruber J; Mathuru AS; Tolwinski NS
Elife; 2020 Mar; 9():. PubMed ID: 32228858
[TBL] [Abstract][Full Text] [Related]
20. Brain Ischemia as a Prelude to Alzheimer's Disease.
Pluta R; Januszewski S; Czuczwar SJ
Front Aging Neurosci; 2021; 13():636653. PubMed ID: 33679381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
